Micellar Nanoformulation of Berberine to Mitigate Doxorubicin-induced Cardiotoxicity: A Cell-line Study
Background: Doxorubicin-induced cardiotoxicity (DIC) is a major complication of cancer chemotherapy. Thus, developing effective myocardial protection strategies during doxorubicin (Dox) therapy is a medical necessity.Objectives: To evaluate and compare the cardioprotective effectiveness of free berb...
Saved in:
| Main Authors: | Noora Alyasari, Anwar Almzaiel |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
University of Anbar
2023-12-01
|
| Series: | Al-Anbar Medical Journal |
| Subjects: | |
| Online Access: | https://amj.uoanbar.edu.iq/article_181120_bc2ef32fefa361cd6a3125c931029fc3.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Synergistic co-administration of doxorubicin and berberine by PLGA/PVA hybrid polymeric Nanoformulation for breast cancer treatment
by: Masoumeh Rahmani, et al.
Published: (2025-04-01) -
Investigate if Metoprolol and Troxerutin Could Prevent Cardiotoxicity Mitigated by Doxorubicin
by: Fouad Zeidan Hamzah, et al.
Published: (2025-07-01) -
The function of PCSK9 in doxorubicin-induced cardiotoxicity and its underlying mechanism
by: Shuai Shi, et al.
Published: (2025-07-01) -
Effect of pimobendan on cytokine levels in doxorubicin-induced cardiotoxicity
by: Burak Dik, et al. -
Pathophysiology of Doxorubicin-Mediated Cardiotoxicity
by: Roberto Arrigoni, et al.
Published: (2025-04-01)